July 23, 2014
1 min read

Dextran filler offers favorable results for nasolabial fold augmentation

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

In a 24-week, evaluator-blinded clinical study, researchers found that dextran-derived injectable filler provided favorable results in the augmentation of the nasolabial folds.

Researchers enrolled 20 patients with nasolabial folds rated as 3 or higher based on the Wrinkle Severity Rating Scale (WSRS). Each patient received one session of dextran filler in both nasolabial folds, with no additional touch-up visit. Follow-up visits occurred at 4, 12 and 24 weeks after initial treatment.

At week 24, WSRS score had improved by two grades in 50% of patients, and by one grade in the other 50%, according to the researchers. Mean WSRS score improvements from baseline were 2, 1.75 and 1.50 at 4, 12 and 24 weeks, respectively.

One mild treatment-related adverse event was reported during the 24 weeks of follow-up.

The researchers suggested that dextran fillers may have longer staying power when compared with hyaluronic acid fillers and may be a more favorable choice.

Disclosure: The authors have no relevant financial disclosures.